Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.88
-0.75 (-0.61%)
At close: Jun 26, 2026, 4:00 PM EDT
116.88
-5.00 (-4.10%)
After-hours: Jun 26, 2026, 6:03 PM EDT
Protagonist Therapeutics Employees
Protagonist Therapeutics had 132 employees as of December 31, 2025. The number of employees increased by 6 or 4.76% compared to the previous year.
Employees
132
Change (1Y)
6
Growth (1Y)
4.76%
Revenue / Employee
$565,366
Profits / Employee
-$875,656
Market Cap
7.84B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Corcept Therapeutics | 730 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
PTGX News
- 10 days ago - Protagonist Therapeutics Transcript: AGM 2026 - Transcripts
- 11 days ago - Protagonist Therapeutics Reports Granting of Inducement Awards - Accesswire
- 17 days ago - Protagonist Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Protagonist Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress - Accesswire
- 26 days ago - Protagonist Therapeutics Slides: Company presentation - Filings
- 4 weeks ago - Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026 - Accesswire
- 6 weeks ago - Protagonist Therapeutics price target raised to $130 from $125 at Citi - TheFly